Abstract

Background and purposeRadiomics is an emerging field of quantitative imaging. The prognostic value of radiomics analysis in patients with localized clear cell renal cell carcinoma (ccRCC) after nephrectomy remains unknown.MethodsComputed tomography images of 167 eligible cases were obtained from the Cancer Imaging Archive database. Radiomics features were extracted from the region of interest contoured manually for each patient. Hierarchical clustering was performed to divide patients into distinct groups. Prognostic assessments were performed by Kaplan–Meier curves, COX regression, and least absolute shrinkage and selection operator COX regression. Besides, transcriptome mRNA data were also included in the prognostic analyses. Endpoints were overall survival (OS) and disease-free survival (DFS). Concordance index (C-index), decision curve analysis and calibration curves with 1,000 bootstrapping replications were used for model’s validation.ResultsHierarchical clustering groups from nephrographic features and mRNA can divide patients into different prognostic groups while clustering groups from corticomedullary or unenhanced phase couldn’t distinguish patients’ prognosis. In multivariate analyses, 11 OS-predicting and eight DFS-predicting features were identified in nephrographic phase. Similarly, seven OS-predictors and seven DFS-predictors were confirmed in mRNA data. In contrast, limited prognostic features were found in corticomedullary (two OS-predictor and two DFS-predictors) and unenhanced phase (one OS-predictors and two DFS-predictors). Prognostic models combining both nephrographic features and mRNA showed improved C-index than any model alone (C-index: 0.927 and 0.879 for OS- and DFS-predicting, respectively). In addition, decision curves and calibration curves also revealed the great performance of the novel models.ConclusionWe firstly investigated the prognostic significance of preoperative radiomics signatures in ccRCC patients. Radiomics features obtained from nephrographic phase had stronger predictive ability than features from corticomedullary or unenhanced phase. Multi-omics models combining radiomics and transcriptome data could further increase the predictive accuracy.

Highlights

  • Renal cell carcinoma (RCC) is the third most prevalent malignancy of urological tumors [1]

  • 11 overall survival (OS)-predicting and eight disease-free survival (DFS)-predicting features were identified in nephrographic phase

  • We firstly investigated the prognostic significance of preoperative radiomics signatures in clear cell RCC (ccRCC) patients

Read more

Summary

Introduction

Renal cell carcinoma (RCC) is the third most prevalent malignancy of urological tumors [1]. It is estimated that 80– 90% RCCs belong to clear cell RCC (ccRCC) [2]. For patients with localized ccRCC, nephrectomy remains to be the standard treatment. Even after surgery, disease progression can still occur in many patients. Due to the tumor heterogeneity, the prognosis of ccRCC varies from cases to cases. Precise prognostic prediction for ccRCC patients is important for patients’ counseling and essential for clinicians making personalized therapeutic decision. Radiomics is an emerging field of quantitative imaging. The prognostic value of radiomics analysis in patients with localized clear cell renal cell carcinoma (ccRCC) after nephrectomy remains unknown

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call